[Seite 62↓]


1. Bienenstock J, Tomioka M, et al.: The role of mast cells in inflammatory processes: evidence for nerve/mast cell interactions. Int Arch Allergy Appl Immunol 1987: 82 (3-4): 238-43.

2. Bienenstock J, MacQueen G, et al.: Mast cell/nerve interactions in vitro and in vivo. Am Rev Respir Dis 1991: 143 (3 Pt 2): S55-8.

3. Kirshenbaum AS, Kessler SW, et al.: Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells. J Immunol 1991: 146 (5): 1410-5.

4. Henz BM, Maurer M, et al.: Mast cells as initiators of immunity and host defense. Exp Dermatol 2001: 10 (1): 1-10.

5. Metcalfe DD, Baram D, et al.: Mast cells. Physiol Rev 1997: 77 (4): 1033-79.

6. Weber S, Kruger-Krasagakes S, et al.: Mast cells. Int J Dermatol 1995: 34 (1): 1-10.

7. Schulman ES, Kagey-Sobotka A, et al.: Heterogeneity of human mast cells. J Immunol 1983: 131 (4): 1936-41.

8. Irani AM, Craig SS, et al.: Deficiency of the tryptase-positive, chymase-negative mast cell type in gastrointestinal mucosa of patients with defective T lymphocyte function. J Immunol 1987: 138 (12): 4381-6.

9. Blank U, Ra C, et al.: Complete structure and expression in transfected cells of high affinity IgE receptor. Nature 1989: 337 (6203): 187-9.

10. Lin S, Cicala C, et al.: The Fc(epsilon)RIbeta subunit functions as an amplifier of Fc(epsilon)RIgamma-mediated cell activation signals. Cell 1996: 85 (7): 985-95.

11. Ra C, Jouvin MH, et al.: Complete structure of the mouse mast cell receptor for IgE (Fc epsilon RI) and surface expression of chimeric receptors (rat-mouse-human) on transfected cells. J Biol Chem 1989: 264 (26): 15323-7.

12. Kihara H, Siraganian RP: Src homology 2 domains of Syk and Lyn bind to tyrosine-phosphorylated subunits of the high affinity IgE receptor. J Biol Chem 1994: 269 (35): 22427-32.

13. Shiue L, Zoller MJ, et al.: Syk is activated by phosphotyrosine-containing peptides representing the tyrosine-based activation motifs of the high affinity receptor for IgE. J Biol Chem 1995: 270 (18): 10498-502.

14. Kinet JP, Jouvin MH, et al.: IgE receptor (Fc epsilon RI) and signal transduction. Eur Respir J Suppl 1996: 22 : 116s-118s.

[Seite innerhalb Literaturhinweis 63↓]

15. Paolini R, Jouvin MH, et al.: Phosphorylation and dephosphorylation of the high-affinity receptor for immunoglobulin E immediately after receptor engagement and disengagement. Nature 1991: 353 (6347): 855-8.

16. Paolini R, Renard V, et al.: Different roles for the Fc epsilon RI gamma chain as a function of the receptor context. J Exp Med 1995: 181 (1): 247-55.

17. Jouvin MH, Adamczewski M, et al.: Differential control of the tyrosine kinases Lyn and Syk by the two signaling chains of the high affinity immunoglobulin E receptor. J Biol Chem 1994: 269 (8): 5918-25.

18. Streb H, Irvine RF, et al.: Release of Ca2+ from a nonmitochondrial intracellular store in pancreatic acinar cells by inositol-1,4,5-trisphosphate. Nature 1983: 306 (5938): 67-9.

19. Hoth M: Depletion of intracellular calcium stores activates an outward potassium current in mast and RBL-1 cells that is correlated with CRAC channel activation. FEBS Lett 1996: 390 (3): 285-8.

20. Wesselborg S, Fruman DA, et al.: Identification of a physical interaction between calcineurin and nuclear factor of activated T cells (NFATp). J Biol Chem 1996: 271 (3): 1274-7.

21. Smorodchenko A, Lippert U, et al.: Expression and translocation of lysosome-associated membrane proteins (LAMPs) in anti IgE-activated human mast cells. Arch Derm Res 2001 abstr.: 293 : 45.

22. Kannan K, Stewart RM, et al.: Lysosome-associated membrane proteins h-LAMP1 (CD107a) and h-LAMP2 (CD107b) are activation-dependent cell surface glycoproteins in human peripheral blood mononuclear cells which mediate cell adhesion to vascular endothelium. Cell Immunol 1996: 171 (1): 10-9.

23. Chang MH, Karageorgos LE, et al.: CD107a (LAMP-1) and CD107b (LAMP-2). J Biol Regul Homeost Agents 2002: 16 (2): 147-51.

24. Bell CR, Horowitz ED, et al.: Profound inhibition of GPIb, GPIIb/IIIa, PECAM-1, CD63, and CD107 in a chronic drug addict: selecting controls for platelet flow cytometry in the inner city hospital. Thromb Res 2001: 101 (3): 217-8.

25. White DM: Release of substance P from peripheral sensory nerve terminals. J Peripher Nerv Syst 1997: 2 (3): 191-201.

26. Suzuki R, Furuno T, et al.: Direct neurite-mast cell communication in vitro occurs via the neuropeptide substance P. J Immunol 1999: 163 (5): 2410-5.

27. Schenker C, Mroz EA, et al.: Release of substance P from isolated nerve endings. Nature 1976: 264 (5588): 790-2.

[Seite innerhalb Literaturhinweis 64↓]

28. Pang X, Boucher W, et al.: Mast cell and substance P-positive nerve involvement in a patient with both irritable bowel syndrome and interstitial cystitis. Urology 1996: 47 (3): 436-8.

29. Nicoll RA, Schenker C, et al.: Substance P as a transmitter candidate. Annu Rev Neurosci 1980: 3 : 227-68.

30. Pawlak M, Schmidt RF, et al.: The neurokinin-1 receptor antagonist RP 67580 reduces the sensitization of primary afferents by substance P in the rat. Eur J Pain 2001: 5 (1): 69-79.

31. Piotrowski W, Devoy MA, et al.: The substance P receptor on rat mast cells and in human skin. Agents Actions 1984: 14 (3-4): 420-4.

32. Piotrowski W, Foreman JC: On the actions of substance P, somatostatin, and vasoactive intestinal polypeptide on rat peritoneal mast cells and in human skin. Naunyn Schmiedebergs Arch Pharmacol 1985: 331 (4): 364-8.

33. de Vries A, Dessing MC, et al.: Nerve growth factor induces a neurokinin-1 receptor- mediated airway hyperresponsiveness in guinea pigs. Am J Respir Crit Care Med 1999: 159 (5 Pt 1): 1541-4.

34. Cocchiara R, Bongiovanni A, et al.: Inhibitory effect of neuraminidase on SP-induced histamine release and TNF-alpha mRNA in rat mast cells: evidence of a receptor-independent mechanism. J Neuroimmunol 1997: 75 (1-2): 9-18.

35. Lieb K, Schaller H, et al.: Substance P and histamine induce interleukin-6 expression in human astrocytoma cells by a mechanism involving protein kinase C and nuclear factor-IL-6. J Neurochem 1998: 70 (4): 1577-83.

36. Krumins SA, Broomfield CA: C-terminal substance P fragments elicit histamine release from a murine mast cell line. Neuropeptides 1993: 24 (1): 5-10.

37. Baumruker T, Prieschl E: Mast Cells and their Activation - from the Molecular Mechanisms to Clinical Relevance. Mod Asp Immunobiol 2001: 1 (6): 256-262.

38. Moqbel R, Lacy P: Exocytotic events in eosinophils and mast cells. Clin Exp Allergy 1999: 29 (8): 1017-22.

39. Buckley IK, Ryan GB: Increased vascular permeability. The effect of histamine and serotonin on rat mesenteric blood vessels in vivo. Am J Pathol 1969: 55 (3): 329-47.

40. Schwartz L, Irani A, et al.: Quantitation of histamine, tryptase and chymase in dispersed human T and TC mast cells. J Immunolog 1987: 138 (8): 2611-2615.

[Seite innerhalb Literaturhinweis 65↓]

41. Schwartz B: Structure and function of human mast cell tryptase. Biological and Molecular Aspects of Mast Cell and Basophil Differentiation and Function - Raven Press, Ltd., NY 1995: .

42. Abe M, Kurosawa M, et al.: Mast cell tryptase stimulates both human dermal fibroblast proliferation and type I collagen production. Clin Exp Allergy 1998: 28 (12): 1509-17.

43. Akimoto S, Ishikawa O, et al.: Dermal mast cells in scleroderma: their skin density, tryptase/chymase phenotypes and degranulation. Br J Dermatol 1998: 138 (3): 399-406.

44. Aldenborg F, Enerback L: The immunohistochemical demonstration of chymase and tryptase in human intestinal mast cells. Histochem J 1994: 26 (7): 587-96.

45. Harvima IT, Naukkarinen A, et al.: Mast cell tryptase and chymase in developing and mature psoriatic lesions. Arch Dermatol Res 1993: 285 (4): 184-92.

46. Jarvikallio A, Naukkarinen A, et al.: Quantitative analysis of tryptase- and chymase-containing mast cells in atopic dermatitis and nummular eczema. Br J Dermatol 1997: 136 (6): 871-7.

47. Ruddle N: Tumor nekrosis factor (TNF-alpha) and lymphotoxin (TNF-beta). Curr Opin Immunol 1992: 4 (3): 327-32.

48. Brazis P, De Mora F, et al.: IgE enhances Fc epsilon RI expression and IgE-dependent TNF-alpha release from canine skin mast cells. Vet Immunol Immunopathol 2002: 85 (3-4): 205-12.

49. Cocchiara R, Bongiovanni A, et al.: Substance P selectively activates TNF-alpha mRNA in rat uterine immune cells: a neuroimmune link. Neuroreport 1997: 8 (13): 2961-4.

50. Coward WR, Okayama Y, et al.: NF-kappaB and TNF-alpha: A Positive Autocrine Loop in Human Lung Mast Cells? J Immunol 2002: 169 (9): 5287-93.

51. Gibbs BF, Wierecky J, et al.: Human skin mast cells rapidly release preformed and newly generated TNF-alpha and IL-8 following stimulation with anti-IgE and other secretagogues. Exp Dermatol 2001: 10 (5): 312-20.

52. Gomez-Guerrero C, Lopez-Armada MJ, et al.: Soluble IgA and IgG aggregates are catabolized by cultured rat mesangial cells and induce production of TNF-alpha and IL-6, and proliferation. J Immunol 1994: 153 (11): 5247-55.

53. Sirota L, Punsky I, et al.: Effect of indomethacin on IL-1beta, IL-6 and TNFalpha production by mononuclear cells of preterm newborns and adults. Acta Paediatr 2000: 89 (3): 331-5.

54. Pujol-Borrell R, Todd I, et al.: HLA class II induction in human islet cells by interferon-gamma plus tumor necrosis factor or lymphotoxin. Nature 1987: 326 (6110): 304-6.

[Seite innerhalb Literaturhinweis 66↓]

55. Oliff A: The role of tumor necrosis factor (cachectin) in cachexia. Cell 1988: 54 (2): 141-2.

56. Tracey K, Fong Y, et al.: Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 1987: 330 (6149): 662-4.

57. Hack C, Aarden L, et al.: Role of cytokines in sepsis. Adv Immunol 1997: 66 : 101-95.

58. Weiss JW, Drazen JM, et al.: Comparative bronchoconstrictor effects of histamine, leukotriene C, and leukotriene D in normal human volunteers. Trans Assoc Am Physicians 1982: 95 : 30-5.

59. Czarnetzki BM, Grabbe J, et al.: Mast cells in the cytokine network: the what, where from and what for. Exp Dermatol 1995: 4 (4 Pt 2): 221-6.

60. Jehle AB, Li Y, et al.: Endotoxin and mast cell granule proteases synergistically activate human coronary artery endothelial cells to generate interleukin-6 and interleukin-8. J Interferon Cytokine Res 2000: 20 (4): 361-8.

61. Kruger-Krasagakes S, Moller A, et al.: Production of interleukin-6 by human mast cells and basophilic cells. J Invest Dermatol 1996: 106 (1): 75-9.

62. Moller A, Lippert U, et al.: Human mast cells produce IL-8. J Immunol 1993: 151 (6): 3261-6.

63. Grabbe J, Haas N, et al.: [The mast cell]. Hautarzt 1994: 45 (1): 55-63; quiz 64.

64. Krutmann J: Ultraviolet A-1 irradiation as a tool to study the pathogenesis of atopic dermatitis. Methods Enzymol 2000: 319 : 296-302.

65. Krutmann J: Phototherapy for atopic dermatitis. Clin Exp Dermatol 2000: 25 (7): 552-8.

66. Krutmann J, Schopf E: High-dose-UVA1 phototherapy: a novel and highly effective approach for the treatment of acute exacerbation of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1992: 176 : 120-2.

67. Grabbe J, Welker P, et al.: High-dose ultraviolet A1 (UVA1), but not UVA/UVB therapy, decreases IgE-binding cells in lesional skin of patients with atopic eczema. J Invest Dermatol 1996: 107 (3): 419-22.

68. Morita A, Kobayashi K, et al.: Ultraviolet A1 (340-400 nm) phototherapy for scleroderma in systemic sclerosis. J Am Acad Dermatol 2000: 43 (4): 670-4.

69. Bruls W, Slaper H, et al.: Transmission of human epidermis and stratum corneum as a function of thickness in the ultraviolet and visibe wavelengths. Photochem Photobiol 1984: 40 (4): 485-94.

70. Kripke ML, Cox PA, et al.: Pyrimidine dimers in DNA initiate systemic immunosuppression in UV-irradiated mice. Proc Natl Acad Sci U S A 1992: 89 (16): 7516-20.

[Seite innerhalb Literaturhinweis 67↓]

71. Yarosh DB: The role of DNA damage and UV-induced cytokines in skin cancer. J Photochem Photobiol B 1992: 16 (1): 91-4.

72. Gilchrest BA, Zhai S, et al.: Treatment of human melanocytes and S91 melanoma cells with the DNA repair enzyme T4 endonuclease V enhances melanogenesis after ultraviolet irradiation. J Invest Dermatol 1993: 101 (5): 666-72.

73. Ceccoli J, Rosales N, et al.: Encapsulation of the UV-DNA repair enzyme T4 endonuclease V in liposomes and delivery to human cells. J Invest Dermatol 1989: 93 (2): 190-4.

74. Kibitel JT, Yee V, et al.: Enhancement of ultraviolet-DNA repair in denV gene transfectants and T4 endonuclease V-liposome recipients. Photochem Photobiol 1991: 54 (5): 753-60.

75. Oh HK, Teo AK, et al.: Conformational change in human DNA repair enzyme O6-methylguanine-DNA methyltransferase upon alkylation of its active site by SN1 (indirect-acting) and SN2 (direct-acting) alkylating agents: breaking a "salt-link". Biochemistry 1996: 35 (38): 12259-66.

76. Wolf P, Yarosh DB, et al.: Effects of sunscreens and a DNA excision repair enzyme on ultraviolet radiation-induced inflammation, immune suppression, and cyclobutane pyrimidine dimer formation in mice. J Invest Dermatol 1993: 101 (4): 523-7.

77. McGregor W: DNA repair, DNA replication, and UV mutagenesis. J investig Dermatol Symp Proc 1999: 4 (1): 1-5.

78. Tada-Oikawa S, Oikawa S, et al.: Role of ultraviolet A-induced oxidative DNA damage in apoptosis via loss of mitochondrial membrane potential and caspase-3 activation. Biochem Biophys Res Commun 1998: 247 (3): 693-6.

79. Sies H: Oxidative stress: from basic research to clinical application. Am J Med 1991: 91 (3C): 31S-38S.

80. Pacifici R, Davies K: Protein, lipid and DNA repair systems in oxidative stress: the free-radical theory of aging revisited. Gerontology 1991: 37 (1-3): 166-80.

81. Pourzand C, Watkin R, et al.: Ultraviolet A radiation induces immediate release of iron in human primary skin fibroblasts: the role of ferritin. Proc Natl Acad Sci USA 1999: 96 (12): 6751-6.

82. Vile G, Tyrell R: UVA radiation-induced oxidative damage to lipids and proteins in vitro and in human skin fibroblasts is dependent on iron and singlet oxygen. Free Radic Biol Med 1995: 18 (4): 721-30.

83. Morliere P, Moysan A, et al.: UVA-induced lipid peroxidation in cultured human fibroblasts. Biochim Biophys Acta 1991: 1084 (3): 261-8.

[Seite innerhalb Literaturhinweis 68↓]

84. Punnonen K, Jansen C, et al.: Effects of in vitro UVA irradiation and PUVA treatment on membrane fatty acids and activities of antioxidants enzymes in human keratinocytes. J Invest Dermatol 1991: 96 (2): 255-9.

85. Cadet J, Voituriez L, et al.: A new class of psoralen photoadducts to DNA components: isolation and characterization of 8-MOP adducts to the osidic moiety of 2'-deoxyadenosine. J Photochem Photobiol B 1988: 2 (3): 321-39.

86. Johnston BH, Johnson MA, et al.: Psoralen-DNA photoreaction: controlled production of mono- and diadducts with nanosecond ultraviolet laser pulses. Science 1977: 197 (4306): 906-8.

87. Pathak MA, Kramer DM: Photosensitization of skin in vivo by furocoumarins (psoralens). Biochim Biophys Acta 1969: 195 (1): 197-206.

88. Liu Z, Lu Y, et al.: PUVA (8-methoxy-psoralen plus ultraviolet A) induces the formation of 8-hydroxy-2'-deoxyguanosine and DNA fragmentation in calf thymus DNA and human epidermoid carcinoma cells. Free Radic Biol Med 1999: 27 (1-2): 127-33.

89. Rae V, Yoshikawa T, et al.: An ultraviolet B radiation protocol for complete depletion of human epidermal Langerhans cells. J Dermatol Surg Oncol 1989: 15 (11): 1199-202.

90. Siraganian RP: Refinements in the automated fluorometric histamine analysis system. J Immunol Methods 1975: 7 (2-3): 283-90.

91. Fritsch P, Vanscheidt W: Flowzytometrie in der Dermatologie. Hautarzt 1996: 47 : 561-578.

92. Nishigori C, Yarosh DB, et al.: Evidence that DNA damage triggers interleukin 10 cytokine production in UV-irradiated murine keratinocytes. Proc Natl Acad Sci U S A 1996: 93 (19): 10354-9.

93. de Vos S, Brach M, et al.: Post-transcriptional regulation of interleukin-6 gene expression in human keratinocytes by ultraviolet B radiation. J Invest Dermatol 1994: 103 (1): 92-6.

94. Petit-Frere C, Clingen PH, et al.: Induction of interleukin-6 production by ultraviolet radiation in normal human epidermal keratinocytes and in a human keratinocyte cell line is mediated by DNA damage. J Invest Dermatol 1998: 111 (3): 354-9.

95. Bernerd F, Asselineau D: UVA exposure of human skin reconstructed in vitro induces apoptosis of dermal fibroblasts: subsequent connective tissue repair and implications in photoaging. Cell Death Differ 1998: 5 (9): 792-802.

96. Guhl S, Hartmann K: Ultraviolet irradiation induces apoptosis in human immature, but not in skin mast cells. in press 2003: .

[Seite innerhalb Literaturhinweis 69↓]

97. Benyon R, Robinson C, et al.: Differential release of histamine and eicosanoids from human skin mast cells activated by IgE-dependent and non-immunological stimuli. Br J Pharmacol 1989: 97 (3): 898-904.

98. Church M, Okayama Y, et al.: Mediator secretion from human skin mast cells provocated by immunological and non-immunological stimulation. Skin Pharmakol 1991: 4 Suppl 1 : 15-24.

99. Cocchiara R, Albeggiani G, et al.: Histamine and Tumor Necrosis Factor production from purified rat brain mast cells mediated by substance P. NeuroReport 1999: 10 (3): 575-578.

100. Janiszewski J, Bienenstock J, et al.: Picomolar doses of substance P trigger electrical responses in mast cells without degranulation. Am J Physiol 1994: 267 (1 Pt 1): C138-45.

101. Okada T, Hirayama Y, et al.: Functional neurokinin NK-1 receptor expression in rat peritoneal mast cells. Inflamm Res 1999: 48 (5): 274-279.

102. Andoh T, Nagasawa T, et al.: Substance P Induction of Itch-Associated Response Mediated by Cutaneus NK1 Tachykinin Receptors in Mice. J Pharmacol Exp Ther 1998: 286 (3): 1140-1145.

103. Brooks A, CJ. W: Reactive oxygen species generation by mast cells in response to substance P: A NK1-receptor-mediated event. Inflamm Res 1999: Suppl 2 : S121.

104. Holst B, Hastrup H, et al.: Two active molecular phenotypes of the tachykinine NK1 receptor revealed by G-protein fusions and mutagenesis. J Biol Chem 2001: 276 (23): 19793-19799.

105. Fiebich BL, Schleicher S, et al.: The neuropeptide substance P activates p38 mitogen-activated protein kinase resulting in IL-6 expression independently from NF-kappa B. J Immunol 2000: 165 (10): 5606-11.

106. Furutani K, Koro O, et al.: Substance P- and antigen-induced release of leukotriene B4, prostaglandin D2 and histamine from guinea pig skin by different mechanisms in vitro. Arch Dermatol Res 1999: 291 (7-8): 166-473.

107. Klinker J, Hagelüken A, et al.: Direct and indirect receptor-independent G-protein activation by cationic-amphiphilic substances: Studies with mast cells, HL-60 human leukemic cells and purified G-proteins. Exp Dermatol 1995: 4 (4 Pt 2): 231-239.

108. Repke H, Bienert M: Mast-cell activation - a receptor-independent mode of substance P action? FEBS Lett 1987: 221 (2): 236-240.

109. Vink AA, Shreedhar V, et al.: Cellular target of UVB-induced DNA damage resulting in local suppression of contact hypersensitivity. J Photochem Photobiol B 1998: 44 (2): 107-11.

[Seite innerhalb Literaturhinweis 70↓]

110. Krutmann J, Morita A: Mechanisms of ultraviolet (UV) B and UVA phototherapy. J Investig Dermatol Symp Proc 1999: 4 (1): 70-2.

111. Vink AA, Henegouwen B, et al.: Removal of UV-induced DNA lesions in mouse epidermis soon after irradiation. J Photochem Photobiol B 1994: 24 (1): 25-31.

112. Vink AA, Moodycliffe AM, et al.: The inhibition of antigen-presenting activity of dendritic cells resulting from UV irradiation of murine skin is restored by in vitro photorepair of cyclobutane pyrimidine dimers. Proc Natl Acad Sci U S A 1997: 94 (10): 5255-60.

113. Park YM, Kim CW: The effects of substance P and vasoactive intestinal peptide on interleukin-6 synthesis in cultured human keratinocytes. J Dermatol Sci 1999 : 22 (1) : 17-23.

114. Okayama Y, Ono Y, et al. : Human skin mast cells produce TNF-alpha by Substance P. Int Arch Allergy Immunol 1998: 117 (Suppl 1): 48-51.

115. Guhl S, Stefaniak R, et al.: Bivalent and immunomodulating impact of UV-light on human skin mast cells - low level mediator release at baseline but potent suppression upon mast cell triggering. in press 2003: .

116. Winchester B: Lysosomal membrane proteins. Eur J Paediatr Neur Review 2001: suppl A : 11-9.

117. Blott E, Griffiths G: Secretory lysosomes. Nat Rev Mol Cell Biol 2002: 3 : 122-31.

118. Monneret G, Benoit Y, et al.: Monitoring of basophil activation using CD63 and CCR3 in allergy to muscle relaxant drugs. Clin Immunol 2002: 102 : 192-9.

© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
XDiML DTD Version 4.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am: